Imexpharm’s gross revenue reaches VND 2,118 billion in first nine months of 2025, up 21%

In September 2025, Imexpharm’s profit before tax surged by 101%, while EBITDA increased by 48%. For the first nine months of 2025, the company’s gross and net...